• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部活检在移植后淋巴细胞增生性疾病评估中的作用

Utility of head and neck biopsies in the evaluation of posttransplant lymphoproliferative disorder.

作者信息

Campisi Paolo, Allen Upton D, Ngan Bo-Yee, Hawkes Michael, Forte Vito

机构信息

Department of Otolaryngology--Head and Neck Surgery, The Hospital for Sick Children, University of Toronto, Toronto, Canada.

出版信息

Otolaryngol Head Neck Surg. 2007 Aug;137(2):296-300. doi: 10.1016/j.otohns.2007.02.020.

DOI:10.1016/j.otohns.2007.02.020
PMID:17666259
Abstract

OBJECTIVE

To determine the diagnostic yield of head and neck biopsies in the evaluation of PTLD in children and to explore whether this yield was related to pretransplant Epstein-Barr virus (EBV) serostatus.

STUDY DESIGN

This is a retrospective study of pediatric, post-solid-organ transplant recipients who have undergone a biopsy in the head and neck region to establish a diagnosis of PTLD.

RESULTS

Fifty-six biopsies were performed in 46 patients four to 120 months after solid-organ transplantation. Biopsies yielded PTLD in 39.1% of patients. The odds of developing PTLD if a patient was seropositive for EBV at the time of transplantation was 0.26 (95% confidence interval, 0.064-1.056; P = 0.054).

CONCLUSIONS

The high diagnostic yield of PTLD suggests that biopsies should be performed if PTLD is suspected in pediatric posttransplant patients. The results demonstrate a trend toward lower risk of PTLD among patients with pretransplant exposure to EBV.

摘要

目的

确定头颈部活检在儿童移植后淋巴组织增生性疾病(PTLD)评估中的诊断率,并探讨该诊断率是否与移植前爱泼斯坦-巴尔病毒(EBV)血清学状态相关。

研究设计

这是一项针对实体器官移植术后接受头颈部活检以确诊PTLD的儿科患者的回顾性研究。

结果

46例患者在实体器官移植后4至120个月进行了56次活检。活检确诊PTLD的患者占39.1%。移植时EBV血清学阳性的患者发生PTLD的几率为0.26(95%置信区间,0.064 - 1.056;P = 0.054)。

结论

PTLD的高诊断率表明,对于疑似PTLD的儿科移植后患者应进行活检。结果显示移植前接触EBV的患者发生PTLD的风险有降低趋势。

相似文献

1
Utility of head and neck biopsies in the evaluation of posttransplant lymphoproliferative disorder.头颈部活检在移植后淋巴细胞增生性疾病评估中的作用
Otolaryngol Head Neck Surg. 2007 Aug;137(2):296-300. doi: 10.1016/j.otohns.2007.02.020.
2
Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.采用客观病例确诊法确定小儿肝移植受者中与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病的危险因素。
Transplantation. 2003 Apr 15;75(7):987-93. doi: 10.1097/01.TP.0000057244.03192.BD.
3
Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.小儿器官移植受者的腺样体扁桃体肥大与爱泼斯坦-巴尔病毒
Laryngoscope. 2001 Jun;111(6):997-1001. doi: 10.1097/00005537-200106000-00013.
4
Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.识别患有爱泼斯坦-巴尔病毒血症的小儿实体器官移植受者移植后淋巴细胞增生性疾病的预测因素。
J Pediatr Hematol Oncol. 2014 Nov;36(8):e481-6. doi: 10.1097/MPH.0000000000000178.
5
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.低剂量化疗用于实体器官移植术后儿童的 Epstein-Barr 病毒阳性移植后淋巴细胞增生性疾病
J Clin Oncol. 2005 Sep 20;23(27):6481-8. doi: 10.1200/JCO.2005.08.074.
6
Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.儿童脐带血移植后发生的移植后淋巴细胞增生性疾病
Am J Surg Pathol. 2006 Mar;30(3):328-36. doi: 10.1097/01.pas.0000188030.63706.e7.
7
Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.完全停用免疫抑制剂作为小儿肝移植术后淋巴组织增生性疾病的统一治疗方法。
Pediatr Transplant. 2004 Jun;8(3):267-72. doi: 10.1111/j.1399-3046.2004.00129.x.
8
A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.一项比较更昔洛韦与更昔洛韦加免疫球蛋白预防爱泼斯坦-巴尔病毒相关移植后淋巴细胞增生性疾病的随机试验。
Transplantation. 2006 Mar 27;81(6):856-61. doi: 10.1097/01.tp.0000202724.07714.a2.
9
Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.实体器官移植受者发生移植后淋巴细胞增生性疾病的遗传易感性证据。
Transplantation. 2007 Aug 15;84(3):387-91. doi: 10.1097/01.tp.0000269617.60751.c4.
10
Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR.采用实时聚合酶链反应对阿根廷移植受者体内的爱泼斯坦-巴尔病毒载量进行定量分析。
J Clin Virol. 2004 Sep;31(1):58-65. doi: 10.1016/j.jcv.2004.02.015.

引用本文的文献

1
Post-transplant lymphoproliferative disorder in an adolescent masquerading as a complicated primary EBV infection.一名青少年伪装成复杂的原发性EB病毒感染的移植后淋巴细胞增生性疾病。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.04.2009.1758. Epub 2009 Jun 9.